Economic evaluation of pharmaceuticals
| dc.contributor.author | O'Brien, Bernie J. | en_US |
| dc.contributor.author | Centre for Health Economics and Policy Analysis | en_US |
| dc.date.accessioned | 2015-04-14T14:41:55Z | |
| dc.date.available | 2015-04-14T14:41:55Z | |
| dc.date.issued | 1995 | en_US |
| dc.description | Bernie O'Brien. | en_US |
| dc.description | Bibliography: p. 23-27. | en_US |
| dc.format.extent | 28 p. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/16980 | |
| dc.publisher | McMaster University | en_US |
| dc.relation.ispartofseries | CHEPA working paper series no. 95-6 | en_US |
| dc.subject | Economics, Pharmaceutical | en_US |
| dc.subject | Cost-Benefit Analysis | en_US |
| dc.subject | Drug Evaluation | en_US |
| dc.subject | Randomized Controlled Trials as Topic | en_US |
| dc.subject | Pharmaceutical Services | en_US |
| dc.subject | economics | en_US |
| dc.title | Economic evaluation of pharmaceuticals | en_US |
| dc.type | text | en_US |